| Pancreatic Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 152show all (up to 200) |
|---|
| → investigated in trials for | Gemcitabinesmall_molecule 175 trials (58 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 175 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 102 trials (45 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 68 trials (29 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 54 trials (21 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall_molecule 51 trials (25 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 51 trials (25 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 34 trials (17 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall_molecule 21 trials (6 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 20 trials (11 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 16 trials (6 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |